1. Home
  2. VKTX vs PRM Comparison

VKTX vs PRM Comparison

Compare VKTX & PRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • PRM
  • Stock Information
  • Founded
  • VKTX 2012
  • PRM 2018
  • Country
  • VKTX United States
  • PRM United States
  • Employees
  • VKTX N/A
  • PRM N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • PRM Newspapers/Magazines
  • Sector
  • VKTX Health Care
  • PRM Consumer Discretionary
  • Exchange
  • VKTX Nasdaq
  • PRM Nasdaq
  • Market Cap
  • VKTX 3.5B
  • PRM 2.9B
  • IPO Year
  • VKTX 2015
  • PRM N/A
  • Fundamental
  • Price
  • VKTX $23.09
  • PRM $21.61
  • Analyst Decision
  • VKTX Strong Buy
  • PRM Strong Buy
  • Analyst Count
  • VKTX 12
  • PRM 2
  • Target Price
  • VKTX $87.50
  • PRM $22.50
  • AVG Volume (30 Days)
  • VKTX 6.8M
  • PRM 1.4M
  • Earning Date
  • VKTX 10-22-2025
  • PRM 11-11-2025
  • Dividend Yield
  • VKTX N/A
  • PRM N/A
  • EPS Growth
  • VKTX N/A
  • PRM N/A
  • EPS
  • VKTX N/A
  • PRM 0.53
  • Revenue
  • VKTX N/A
  • PRM $609,317,000.00
  • Revenue This Year
  • VKTX N/A
  • PRM N/A
  • Revenue Next Year
  • VKTX N/A
  • PRM $5.33
  • P/E Ratio
  • VKTX N/A
  • PRM $41.04
  • Revenue Growth
  • VKTX N/A
  • PRM 56.87
  • 52 Week Low
  • VKTX $18.92
  • PRM $8.76
  • 52 Week High
  • VKTX $81.73
  • PRM $23.79
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 32.25
  • PRM 59.62
  • Support Level
  • VKTX $24.82
  • PRM $20.89
  • Resistance Level
  • VKTX $26.50
  • PRM $22.65
  • Average True Range (ATR)
  • VKTX 1.18
  • PRM 0.81
  • MACD
  • VKTX -0.20
  • PRM -0.24
  • Stochastic Oscillator
  • VKTX 2.47
  • PRM 24.66

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About PRM Perimeter Solutions SA

Perimeter Solutions Inc is a solutions provider for the Fire Safety and Specialty Products industries. The Company's products and operations are managed and reported in two operating segments. Its Fire Safety segment provides fire retardants and firefighting foams, as well as specialized equipment and services typically offered in conjunction with the Company's retardant and foam products. The Specialty Products segment includes operations that develop, produce and market products for non-fire safety markets. Specialty Products segment is Phosphorus Pentasulfide (P2S5) based lubricant additives. P2S5 is also used in pesticide and mining chemicals applications, and emerging electric battery technologies.

Share on Social Networks: